Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

近日，智飞生物全资子公司安徽智飞龙科马自主研发的 带状疱疹mRNA疫苗临床试验申请正式获得国家药品监督管理局受理 ...

The U.S. Senate’s Permanent Subcommittee on Investigations held a crucial hearing titled "The Corruption of Science and ...

近年来，癌症“治疗性疫苗”成为全球肿瘤免疫治疗中增长最快的领域。我国自主研发的 新生抗原mRNA癌症疫苗LK101已获得了美国FDA临床试验批件 ，此外LK101也在多项临床研究中展现出可观的抗肿瘤活性。在2024年ASCO ...

Donald Trump's health is once again under scrutiny after it was revealed that he received three mRNA injections linked to ...

Discover why Cartesian Therapeutics, Inc. earns a Buy rating with strong CAR-T pipeline progress and market growth in ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

每经AI快讯，有投资者在投资者互动平台提问：董秘您好，公司与马来西亚政府合作开发多价mRNA流感疫苗进展如何？谢谢！

The Senate Homeland Security and Governmental Affairs Committee held a powerful hearing on vaccine injury testimonies. Among ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...